The effects of royal jelly on autoimmunity in Graves' disease

Endocrine

Volumn 30, Issue 2, 2006, Pages 175-183

  Erem, Cihangir ^a   Deger, Orhan ^a   Ovali, Ercüment ^a   Barlak, Yasam ^a  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

Autoimmunity; Cytokines; Graves' disease; Lymphocyte cell culture; Royal jelly

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; ROYAL JELLY; THYROTROPIN RECEPTOR ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; AUTOIMMUNITY; CELL ISOLATION; CELL PROLIFERATION; CLINICAL ASSESSMENT; CONTROLLED STUDY; CULTURE MEDIUM; DRUG MECHANISM; ENZYME IMMUNOASSAY; GRAVES DISEASE; HOSPITAL ADMISSION; HUMAN; HUMAN CELL; IMMUNOMODULATION; LABORATORY TEST; LYMPHOCYTE; LYMPHOCYTE CULTURE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; RADIORECEPTOR ASSAY; SENSITIVITY ANALYSIS; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TH1 CELL; TH2 CELL;

EID: 33847375472     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1385/ENDO:30:2:175     Document Type: Article

References (64)

1. Jones, B. M., Kwok, C. C. H., and Kung, A. W. C. (1999). J. Clin. Endocrinol. Metab. 84, 4106-4110.
2. Davies, T. F. (2000). Graves' disease. In: Werner and Igbar's the thyroid. 8th ed. Braverman, L. E. and Utiger, R. D. (eds.). Lippincott-Raven: Philadelphia, pp. 518-555.
3. Itoh, M., Uchimura, K., Makino, M., et al. (2000). Cytokine 12, 688-693.
4. Ajjan, R. A. and Weetman, A. P. (2003). Autoimmunity 36, 351-359.
5. Ward, L. S. and Fernandes, G. A. (2000). Braz. J. Med. Res. 33, 65-69.
6. Mosmann, T. R., Cherwinski, H., Bond, M. W., Giedlin, M. A., and Coffman, R. L. (1986). J. Immunol. 136, 2348-2357.
7. Weetman, A. P. (2004). Clin. Endocrinol. 61, 405-413.
8. Swain, S. L., Weinberg, A. D., English, M., and Huston, G. (1990). J. Immunol. 145, 3796-3806.
9. Cooper, D. S. (2000). In: Werner and Igbar's the thyroid. 8th ed. Braverman, L. E. and Utiger, R. D. (eds.). Lippincott-Raven: Philadelphia, pp. 691-715.
10. Teng, C. S. and Yeung, R. T. (1980). J. Clin. Endocrinol. Metab. 50, 144-147.
11. McGregor, A. M., Petersen, M. M., McLachlan, S. M., Rooke, P., Smith, B. R., and Hall, R. (1980). N. Engl. J. Med. 303, 302-307.
12. Weetman, A. P., McGregor, A. M., and Hall, R. (1983). Clin. Immunol. Immunopathol. 28, 39-45.
13. Piana, L., Manzi, L., and Krell, R. (1996). Royal jelly. http/www.fao.org/docrep/w0076E/w0076e16.htm (last accessed October 2006).
14. Sver, L., Orsolic, N., Tadic, Z., Nijari, B., Valpotic, I., and Basic, I. (1996). Comp. Immunol. Microbiol. Infect. Dis. 19, 31-38.
15. Oka, H., Emori, Y., Kobayashi, N., Hayashi, H., and Nomoto, K. (2001). Int. Immunopharmacol. 1, 521-532.
16. Sauerwald, N., Polster, J., Bengsch, E., Niessen, L., and Vogel, R. F. (1998). Adv. Food Sci. 20, 46-52.
17. Nagai, T., Sakai, M., Inoue, R., Inoue, H., and Suzuki, N. (2001). Food Chem. 75, 237-240.
18. Okuda, H., Kameda, K., Morimoto, C., Matsuura, Y., Chiaki, M., and Jiang, M. (1998). Honeybee Science 19, 9-14.
19. Tamura, T., Fuji, A., and Kuboyama, N. (1987). Folia. Pharmacol. Japon [in Japanase] 89, 73-80.
20. Shinodo, M., Nakajin, S., Oikawa, T., Sato, K., Kamogawa, A., and Akiyama, Y. (1978). Yakugaku Zasshi [in Japanase] 98, 139-145.
21. Vittek, J. (1995). Experientia 51, 927-935.
22. Tokunaga, K.-H., Yoshida, C., Suzuki, K.-M., et al. (2004). Biol. Pharm. Bull. 27, 189-192.
23. Kataoka, M., Arai, N., Taniguchi, Y., et al. (2001). Natural Medicines [in Japanase] 55, 174-180.
24. Kamakura, M., Mitani, N., Fukuda, T., and Fukushima, M. (2001). J. Nutr. Sci. Vitaminol. 47, 394-401.
25. Fujii, A., Kobayashi, S., Kuboyama, N., et al. (1990). Jpn. J. Pharmacol. 53, 331-337.
26. Emori, Y., Oka, H., Ohya, O., Tamaki, H., and Hayashi, H. (1998). Biotherapy (Jpn.) 12, 313-319.
27. Emori, Y., Oka, H., Ohya, O., Tamaki, H., Hayashi, H., and Nomoto, K. (1998). Biotherapy (Jpn.) 12, 1143-1148.
28. Emori, Y., Oka, H., Kobayashi, Y., Ohya, O., Tamaki, H., and Hayashi, H. (1999). Biotherapy (Jpn.) 13, 281-287.
29. Majtan, J., Kovacova, E., Bilikova, K., and Simuth, J. (2006). Int. Immunopharmacol. 6, 269-278.
30. Xie, J., Liu, G., and Liu, K. (1990). Zhongguo Yaoke Daxue Xuebao 21, 167-169.
31. Liu, L. S., Xiao, X. M., and Ziheng, R. C. (1984). Chung Hua Fang She I Hsueh Yu Fang Hu Tsa Chih 4, 25-26.
32. Kohno, K., Okamoto, I., Sano, O., et al. (2004). Biosci. Biotechnol. Biochem. 68, 138-145.
33. Simuth, J., Bilikova, K., Kovacova, E., Kuzmova, Z., and Schroder, W. (2004). J. Agric. Food Chem. 52, 2154-2158.
34. Koya-Miyata, S., Okamoto, I., Ushio, S., Iwaki, K., Ikeda, M., and Kurimoto, M. (2004). Biosci. Biotechnol. Biochem. 68, 767-773.
35. Okamoto, I., Taniguchi, Y., Kunikata, T., et al. (2003). Life Sci. 73, 2029-2045.
36. Pollard, J. M. and Walker, J. M. (1997). Basic cell culture protocols. 2nd ed. Humana Press: Totowa, NJ.
37. Carmichael, J., DeGraff, W. G., Gazdar, A. F., Mina, J. D., and Mitchel, J. B. (1987). Cancer Res. 47, 936-942.
38. Kamakura, M., Suenobu, N., and Fukushima, M. (2001). Biochem. Biophys. Res. Commun. 282, 865-874.
39. Al-Humaidi, M. A. (2000). Saudi Med. J. 21, 639-644.
40. Kocjan, T., Wraber, B., Repnik, U., and Hojker, S. (2000). Pflugers Arch. 440(5 Suppl), R94-R95.
41. Phenekos, C., Vryonidou, A., Gritzapis, A. D., Baxevanis, C. N., Goula, M., and Papamichail, M. (2004). Neuroimmunomodulation 11, 209-213.
42. McLachlan, S. M., Taverne, J., Atherton, M. C., et al. (1990). Clin. Exp. Immunol. 79, 175-181.
43. Kocjan, T., Wraber, B., Kocijancic, A., and Hojker, S. (2004). J. Endocrinol. Invest. 27, 302-307.
44. Taniguchi, Y., Kohno, K., Inoue, S. I., et al. (2003). Int. Immunopharmacol. 3, 1313-1324.
45. Ajjan, R. A., Watson, P. F., and Weetman, A. P. (1996). Adv. Neuroimmunol. 6, 359-386.
46. Pang, X. P., Hershman, J. M., Chang, M., and Eugene, A. (1989). Endocrinology 125, 1783-1788.
47. Diez, J. J., Hernanz, A., Medina, S., Bayon, C., and Iglesias, P. (2002). Clin. Endocrinol. 57, 515-521.
48. Çelik, I., Akalin, S., and Erbas, T. (1995). Eur. J. Endocrinol. 132, 668-672.
49. Senturk, T., Kocaci, L. D., Kok, F., Kadikoylu, G., and Bolaman, Z. (2003). Clin. Invest. Med. 26, 58-63.
50. Chopra, I. J., Sakane, S., and Chuo Teco, G. N. (1991). J. Clin. Endocrinol. Metab. 72, 1113-1116.
51. Hidaka, Y., Okumura, M., Fukata, S., et al. (1999). Thyroid 9, 149-153.
52. Miyauchi, S., Matsuura, B., and Onji, M. (2000). Thyroid 10, 815-819.
53. Tamaru, M., Matsuura, B., and Onji, M. (1999). Eur. J. Endocrinol. 141, 111-116.
54. Mysliwiec, J., Kretowski, A., Topolska, J., et al. (2001). Horm. Metab. Res. 33, 739-743.
55. Bossowski, A. and Urban, M. (2001). J. Pediatr. Endocrinol. Metab. 14, 741-747.
56. Mysliwiec, J., Kretowski, A., Szelachowska, M., Mikita, A., and Kinalska, I. (1999). Rocz. Akad. Med. Bialymst. 44, 160-169.
57. Mysliwiec, J., Kretowski, A., Stepien, A., Mironczuk, K., and Kinalska, I. (2003). Int. Immunopharmacol. 3, 549-552.
58. Takeoka, K., Watanabe, M., Matsuzuko, F., Miyauchi, A., and Iwatani, Y. (2004). Thyroid 14, 201-205.
59. Akamizu, T. (2003). Autoimmunity 36, 361-366.
60. Komiya, I., Yamada, T., Sato, A., Kouki, T., Nishimori, T., and Takasu, N. (2001). J. Clin. Endocrinol. Metab. 86, 3540-3544.
61. Wiktorska, J., Lewinski, A., and Sewerynem, E. (2002). Endokrynologia Polska 53, 357-363.
62. Wilson, R., McKillop, J. H., Pearson, C., Burnett, A. K., and Thomson, J. A. (1988). Clin. Exp. Immunol. 73, 312-315.
63. Michelangeli, V., Poon, C., Taft, J., Newnham, H., Topliss, D., and Colman, P. (1998). Thyroid 8, 119-124.
64. McLachlan, S. M., Taverne, J., Atherton, M. C., et al. (1990). Clin. Exp. Immunol. 79, 175-181.